2020
DOI: 10.1111/pcmr.12946
|View full text |Cite
|
Sign up to set email alerts
|

NRF2‐dependent stress defense in tumor antioxidant control and immune evasion

Abstract: The transcription factor NRF2 is known as the master regulator of the oxidative stress response. Tumor entities presenting oncogenic activation of NRF2, such as lung adenocarcinoma, are associated with drug resistance, and accumulating evidence demonstrates its involvement in immune evasion. In other cancer types, the KEAP1/NRF2 pathway is not commonly mutated, but NRF2 is activated by other means such as radiation, oncogenic activity, cytokines, or other pro‐oxidant triggers characteristic of the tumor niche.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 119 publications
(147 reference statements)
0
15
0
Order By: Relevance
“…To further explore the function of NFE2L3, we combined data from public databases to analyze the possible biological functions of NFE2L3 in the body from the point of view of bioinformatics. Increasing evidence indicates that NFE2L2, a protein that is homologous to the NFE2L3 transcription factor, is involved in immune evasion and is associated with immune infiltration of low-grade gliomas [ 31 , 32 ]. We then used TIMER 2.0 ( http://timer.comp-genomics.org ) to predict the association between NFE2L3 expression and immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…To further explore the function of NFE2L3, we combined data from public databases to analyze the possible biological functions of NFE2L3 in the body from the point of view of bioinformatics. Increasing evidence indicates that NFE2L2, a protein that is homologous to the NFE2L3 transcription factor, is involved in immune evasion and is associated with immune infiltration of low-grade gliomas [ 31 , 32 ]. We then used TIMER 2.0 ( http://timer.comp-genomics.org ) to predict the association between NFE2L3 expression and immune cells.…”
Section: Discussionmentioning
confidence: 99%
“…High Nrf2 tumors were highly infiltrated by immune cells (CD8+, CD4+, and DCs) and stromal cells (adipocytes, fibroblasts, and keratinocytes [124]. In contrast, the negative effects of Nrf2 expression have been reported for glioblastoma [125] and lung adenocarcinoma [126]. Tumor entities presenting oncogenic activation of Nrf2 were found to be associated with drug resistance and immune evasion [125,126].…”
Section: Mitohormesis Macrophages and Case Reportsmentioning
confidence: 99%
“…Nuclear factor erythroid 2-related factor 2 (Nrf2) / phosphatase and tensin homologue (PTEN) plays an important role in antitumor immunity [ 27 , 28 ]. We found morphine increased Nrf2 and decreased PTEN expression in A549 and H460 cells, while naringin (PTEN activator, 150 μM) decreased MAEL expression induced by morphine (Fig.…”
Section: Resultsmentioning
confidence: 99%